Overview
Jong-won Chung practices in Seoul, Republic of Korea. Chung is rated as an Advanced expert by MediFind in the treatment of Autonomic Neuropathy. Their top areas of expertise are Stroke, Moyamoya Disease, Atherosclerosis, Thrombectomy, and Stent Placement.
Their clinical research consists of co-authoring 130 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Autonomic Neuropathy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- StrokeChung isDistinguished. Learn about Stroke.
- Advanced
- AtherosclerosisChung isAdvanced. Learn about Atherosclerosis.
- Atrial FibrillationChung isAdvanced. Learn about Atrial Fibrillation.
- Autonomic NeuropathyChung isAdvanced. Learn about Autonomic Neuropathy.
- Moyamoya DiseaseChung isAdvanced. Learn about Moyamoya Disease.
- ThrombectomyChung isAdvanced. Learn about Thrombectomy.
- Experienced
- Aortic DissectionChung isExperienced. Learn about Aortic Dissection.
- Arterial Tortuosity SyndromeChung isExperienced. Learn about Arterial Tortuosity Syndrome.
- Carotid Artery DiseaseChung isExperienced. Learn about Carotid Artery Disease.
- Diabetic NeuropathyChung isExperienced. Learn about Diabetic Neuropathy.
- Disseminated Intravascular Coagulation
- Facial ParalysisChung isExperienced. Learn about Facial Paralysis.